Gastroenteritis, diarrhea
Conditions
Interventions
Control group:None
Observation group:None
Sponsors
Shantou Chenghai District People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)The clinical diagnosis is gastroenteritis. (2) There are clinical symptoms of varying degrees such as vomiting, diarrhea and abdominal pain. (3) The shape of the stool changes, presenting as loose, watery, mucous or bloody stool. (4) The frequency of bowel movements has increased compared to usual. (5) No dehydration or poisoning symptoms, and the general condition is good. (6) Voluntarily participated in the trial and signed the informed consent form for the trial research. (7) The experimental group took Bifidobacterium brevis FPHC4024 probiotics (food) for >=7 days, while the control group did not take any probiotics.
Exclusion criteria
Exclusion criteria: (1) Surgical history; (2) Digestive system malformations; (3) Gene therapy within the last 6 months. (4) Pregnant or lactating women or those with plans to conceive within 3 months; (5) Those who did not consume the test sample, or whose data is incomplete and affects the judgment of efficacy or safety. (6)Concurrent use of other probiotics, antibiotics, immunosuppressants, or other drugs or foods that may interfere with the results.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compare the intervention effects between groups;The distribution of probiotics in feces, especially the abundance of newly colonized probiotics and Enterococcus faecalis.;Subjective feelings of consumption; | — |
Secondary
| Measure | Time frame |
|---|---|
| During the follow-up, the fecal properties and defecation frequency of the patients were observed.; | — |
Countries
China
Contacts
Public ContactHan Hui
Shantou Chenghai District People's Hospital
Outcome results
None listed